NEGG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NEGG is not a clear buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The stock is technically oversold and has a short-term rebound setup, but the broader trend is still bearish and the latest quarter showed declining revenue despite improved profitability. Because the user is impatient and wants a direct answer, my view is to hold off on buying aggressively now; the current setup is more suitable for traders than a long-term beginner entry.
NEGG is in a weak primary trend. The MACD histogram is negative at -0.0686, though it is contracting, which hints that downside momentum may be easing. RSI_6 is very low at 14.321, showing the stock is deeply oversold and could bounce short term. However, moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, confirming the longer trend is still down. Price is near support, with S1 at 17.357 and current pre-market price around 18.43, slightly above support but still below the pivot at 20.025. This makes the setup more of a possible tactical bounce than a confirmed long-term trend reversal.
Recent quarterly results showed improved profitability: Q1 net income turned positive at $7.8 million versus a $2.5 million loss last year, gross profit rose 10.3% to $43.7 million, and adjusted EBITDA improved to $10.0 million from $5.4 million year-over-year. The stock is also technically oversold, which can support a near-term rebound if buyers step in.
Q1 revenue fell 11.8% year-over-year to $306.2 million, showing the top line is still shrinking. The broader trend remains bearish based on moving averages and MACD. Hedge funds and insiders are both neutral, so there is no strong ownership-driven catalyst. The similarity-based stock trend also points to weakness over the next month at -4.68%.
Latest quarter: Q1. Revenue was $306.2 million, down 11.8% year-over-year, which is negative for growth. However, the company improved operationally with net income of $7.8 million versus a $2.5 million loss a year earlier, gross profit up 10.3% to $43.7 million, and adjusted EBITDA up to $10.0 million from $5.4 million. Overall, the quarter shows better profitability but weaker sales growth.
No analyst rating or price target data was provided, so there is no clear evidence of a recent Wall Street upgrade or target increase. Based on the available information, Wall Street’s pros would likely focus on profitability improvement and oversold conditions, while the cons would center on falling revenue and the still-bearish technical trend. Overall, the pro-con view is mixed rather than strongly bullish.
